The vaccine could be available for emergency use authorisation in early 2021. BENGALURU - Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorisation in early 2021. J&J also said it had committed more than $1 billion of investment along with US agency Biomedical Advanced Research and Development Authority to co-fund vaccine research.